Mehmet Altan

机构：The University of Texas MD Anderson Cancer Center, Ankara University, University of Health Science, Sağlık Bilimleri Üniversitesi, University of Health Sciences Antigua · ORCID：0000-0001-9229-156X

发表论文 320 篇 · 总被引 7801 次 · h-index 40

代表论文

• Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples (2025 · Nature Communications · 被引 27)
• LBA72 NorthStar: A phase II randomized study of osimertinib (OSI) with or without local consolidative therapy (LCT) for metastatic EGFR-mutant non-small cell lung cancer (NSCLC) (2025 · Annals of Oncology · 被引 15)
• Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC (2025 · Nature Communications · 被引 8)
• Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis (2025 · Frontiers in Medicine · 被引 5)
• Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study (2025 · Breast Cancer Research · 被引 4)
• Macrophage CCL18 promotes lung inflammation in checkpoint inhibitor pneumonitis (2025 · American Journal of Respiratory Cell and Molecular Biology · 被引 4)